HUBEI PROVINCE, CHINA -- (MARKET WIRE) -- May 21, 2007 -- Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTCBB: BPMA), a China-based pharmaceutical company producing conventional and Traditional Chinese Medicines, as well as Genedicine,® the world’s first commercialized gene therapy medicine for the treatment of cancer, has announced operating results for the quarter ended March 31, 2007.
